Outlook Therapeutics, Inc. (OTLK) 8-K filings
- Ticker
- OTLK (Nasdaq)
- SEC CIK
- 1649989
- Industry (SIC)
- 2836 Biological Products, (No Diagnostic Substances)
- Incorporated in
- DE
- All filings
- SEC EDGAR
Recent 8-Ks
| Accepted (ET) | Form | Items | Filing |
|---|---|---|---|
| 2026-09-30 16:30 | 8-K | 3.01 Listing notice | Details |
| 2026-09-18 16:30 | 8-K | 8.01 Other events | Details |
| 2026-08-27 16:11 | 8-K | 5.02 Executive or director change | Details |